CD34 and acute myeloid leukemia: Consistent with this interpretation of our data are for example findings showing that blast cell numbers [43] or a high number of CD34+ in the BM of AML patients [44], [45] correlated with shorter survival, supporting a relationship between higher leukemia-initiating cell burden and poor prognosis.